← Back to guidelines
Urology20 papers

Acquired obstructive defect of renal pelvis

Last edited: 4/15/2026

Overview

Acquired obstructive defects of the renal pelvis involve structural abnormalities that impede urine flow from the kidney to the ureter, often secondary to conditions like stones, tumors, or strictures 1.

Diagnosis

  • Imaging: MRI with optimized RF resonators can enhance diagnostic accuracy, particularly in urological imaging 1.
  • Ultrasound: Initial screening tool to identify structural abnormalities.
  • Urodynamic studies: Assess functional obstruction and urine flow dynamics.
  • Renal function tests: Evaluate for signs of hydronephrosis or impaired renal function.
  • Management

  • Surgical intervention: Primary treatment for definitive relief of obstruction, including procedures like nephrostomy, stent placement, or reconstructive surgery 1.
  • Endourological procedures: Minimally invasive techniques such as ureteroscopy for stone removal or stricture dilation.
  • Medical management: Pain control and hydration; specific drug classes not detailed in provided abstracts.
  • Special Populations

  • Pregnancy: Management strategies need careful consideration to avoid teratogenic risks; specific guidelines not provided 1.
  • Pediatrics: Endourological approaches may differ due to anatomical variations; tailored surgical interventions are crucial 1.
  • Elderly: Increased risk of comorbidities; multidisciplinary care is recommended to manage coexisting conditions 1.
  • Comorbidities: Presence of conditions like diabetes or cardiovascular disease may influence surgical risk and recovery; individualized treatment plans are essential 1.
  • Key Recommendations

  • Utilize advanced MRI techniques with optimized RF resonators for enhanced diagnostic imaging in suspected cases of acquired obstructive defects (Evidence: Expert opinion 1).
  • Prioritize surgical interventions tailored to the specific cause of obstruction for definitive treatment (Evidence: Expert opinion 1).
  • Consider patient-specific factors such as age and comorbidities when planning management strategies to optimize outcomes (Evidence: Expert opinion 1).
  • References

    1 Koreshin E, Efimtcev A, Gulko A, Popov S, Orlov I, Trufanov G et al.. Design of a RF-resonant set improving locally the B1+ efficiency. Applications for clinical MRI in andrology and urology. Journal of magnetic resonance (San Diego, Calif. : 1997) 2020. link

    Original source

    1. [1]
      Design of a RF-resonant set improving locally the B1+ efficiency. Applications for clinical MRI in andrology and urology.Koreshin E, Efimtcev A, Gulko A, Popov S, Orlov I, Trufanov G et al. Journal of magnetic resonance (San Diego, Calif. : 1997) (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG